Zobrazeno 1 - 10
of 100
pro vyhledávání: '"M. Hurry"'
Autor:
S. Hassan, Andrew Aw, Jonathan J. Edwin, Soo Jin Seung, M. Hurry, Krystin A. B. Scheider, Ashlie Elnoursi, Dennis Wagner
Publikováno v:
Current Oncology
Volume 28
Issue 6
Pages 408-4844
Current Oncology, Vol 28, Iss 408, Pp 4832-4844 (2021)
Volume 28
Issue 6
Pages 408-4844
Current Oncology, Vol 28, Iss 408, Pp 4832-4844 (2021)
Information on the real-world experience of Canadians diagnosed with chronic lymphocytic leukemia (CLL) is limited. This study was conducted to report treatment patterns and outcomes of CLL using Ontario administrative data. A retrospective cohort st
Autor:
M. Hurry, R. Walton, Goulnar Kasymjanova, M. Lecavalier, Jason Agulnik, C. Pepe, D. Small, Victor Cohen, L. Sakr
Publikováno v:
Curr Oncol
Current Oncology
Volume 27
Issue 5
Pages 6241-466
Current Oncology
Volume 27
Issue 5
Pages 6241-466
A retrospective cohort study considered patients 18 or more years of age diagnosed between January 2007 and May 2018 with unresectable stage iii non-small-cell lung cancer (nsclc) who received combined chemoradiation (crt). Survival was analyzed usin
Publikováno v:
International Journal of Technology Assessment in Health Care. 36:104-112
ObjectivesTo assess the cost effectiveness from a Canadian perspective of index patient germline BRCA testing and then, if positive, family members with subsequent risk-reducing surgery (RRS) in as yet unaffected mutation carriers compared with no te
Autor:
Alexander G. Ivanov, Marianna Krol, Leonid V. Savitch, Beth Szyszka-Mroz, Jessica Roche, D. P. Sprott, Eva Selstam, Kenneth W. Wilson, Richard Gardiner, Gunnar Öquist, Vaughan M. Hurry, Norman P. A. Hüner
Publikováno v:
Planta. 255
Publikováno v:
THE 9TH INTERNATIONAL CONFERENCE ON APPLIED SCIENCE AND TECHNOLOGY (ICAST 2021).
Publikováno v:
THE 9TH INTERNATIONAL CONFERENCE ON APPLIED SCIENCE AND TECHNOLOGY (ICAST 2021).
Autor:
Christie Farrer, Winson Y. Cheung, Natalie Devost, Dimas Yusuf, R. Walton, M. Hurry, Atul Batra
Publikováno v:
American journal of clinical oncology. 44(10)
Background Treatment strategies for metastatic non-small cell lung cancer (NSCLC) are evolving rapidly and can be highly variable. Real-world evidence of treatment patterns and outcomes can provide an understanding of our current practice and offer i
Autor:
Alexander G, Ivanov, Marianna, Krol, Leonid V, Savitch, Beth, Szyszka-Mroz, Jessica, Roche, D P, Sprott, Eva, Selstam, Kenneth W, Wilson, Richard, Gardiner, Gunnar, Öquist, Vaughan M, Hurry, Norman P A, Hüner
Publikováno v:
Planta. 255(2)
Decreased PG constrains PSI activity due to inhibition of transcript and polypeptide abundance of light-harvesting and reaction center polypeptides generating a reversible, yellow phenotype during cold acclimation of pgp1. Cold acclimation of the Ara
Autor:
Justine Baek, Lawson Eng, Devalben Patel, Grainne M. O'Kane, Mindy Liang, R. Walton, RuiQi Chen, Elliot Charles Smith, Sze Wah Samuel Chan, Geoffrey Liu, Catherine Labbé, Penelope A. Bradbury, Katrina Hueniken, Shirley Xue Jiang, Adrian G. Sacher, M. Hurry, Alexandra McCartney, Catherine Brown, Wei Xu, Natasha B. Leighl, Frances A. Shepherd
Publikováno v:
Cancer Medicine, Vol 8, Iss 18, Pp 7542-7555 (2019)
Cancer Medicine
Cancer Medicine
Background As the treatment landscape in patients with non‐small cell lung cancer (NSCLC) harboring mutations in the epidermal growth factor receptor (EGFRm) continues to evolve, real‐world health utility scores (HUS) become increasingly importan
Publikováno v:
Current Oncology
Volume 27
Issue 4
Pages 6049-367
Volume 27
Issue 4
Pages 6049-367
Almost half of all patients with non-small-cell lung cancer (nsclc) present with stage iv disease. The objective of the present study was to characterize treatment patterns and survival outcomes in patients with advanced nsclc. We conducted a longitu